BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37382594)

  • 21. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis.
    Chen WL; Jiang L; Wang JS; Liao CX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10874-10885. PubMed ID: 31858556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting RAF1.
    Liu Z; Liu Y; Li L; Xu Z; Bi B; Wang Y; Li JY
    Tumour Biol; 2014 Oct; 35(10):10177-84. PubMed ID: 25027403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids.
    Doğanlar O; Doğanlar ZB; Delen E; Doğan A
    Tissue Cell; 2021 Dec; 73():101617. PubMed ID: 34418770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LINC01579 promotes cell proliferation by acting as a ceRNA of miR-139-5p to upregulate EIF4G2 expression in glioblastoma.
    Chai Y; Xie M
    J Cell Physiol; 2019 Dec; 234(12):23658-23666. PubMed ID: 31187495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-491-5p regulates the susceptibility of glioblastoma to ferroptosis through TP53.
    Jie XF; Li YP; Liu S; Fu Y; Xiong YY
    Biochem Biophys Res Commun; 2023 Sep; 671():309-317. PubMed ID: 37327702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
    Zhang S; Liao K; Miao Z; Wang Q; Miao Y; Guo Z; Qiu Y; Chen B; Ren L; Wei Z; Lin Y; Lu X; Qiu Y
    Neuro Oncol; 2019 Oct; 21(10):1284-1296. PubMed ID: 31504797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma.
    Ren S; Xu Y
    Cancer Sci; 2019 May; 110(5):1621-1632. PubMed ID: 30888082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.
    Chen W; Li Q; Zhang G; Wang H; Zhu Z; Chen L
    J Cell Mol Med; 2020 Oct; 24(20):11755-11767. PubMed ID: 32918360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
    Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
    Xu H; Hu Y; Qiu W
    Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p.
    Zhang J; Furuta T; Sabit H; Tamai S; Jiapaer S; Dong Y; Kinoshita M; Uchida Y; Ohtsuki S; Terasaki T; Zhao S; Nakada M
    Cancer Sci; 2020 Jul; 111(7):2413-2422. PubMed ID: 32324311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of ZMYND11 induced by miR-196a-5p promotes the progression and growth of GBM.
    Yang JP; Yang JK; Li C; Cui ZQ; Liu HJ; Sun XF; Geng SM; Lu SK; Song J; Guo CY; Jiao BH
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):674-680. PubMed ID: 29066350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-575 acts as a novel oncogene via targeting multiple signaling pathways in glioblastoma.
    Gray A; Cui T; Bell EH; McElroy J; Sebastian E; Li F; Geurts M; Liu K; Robe P; Haque SJ; Chakravarti A
    Exp Mol Pathol; 2022 Oct; 128():104813. PubMed ID: 35901926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA OIP5-AS1 inhibition upregulates microRNA-129-5p to repress resistance to temozolomide in glioblastoma cells via downregulating IGF2BP2.
    Wang X; Li X; Zhou Y; Huang X; Jiang X
    Cell Biol Toxicol; 2022 Dec; 38(6):963-977. PubMed ID: 34132932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme.
    Dai S; Wang X; Li X; Cao Y
    Biochem Biophys Res Commun; 2015 Nov; 467(2):204-10. PubMed ID: 26449464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
    Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D
    Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA-RNCR3 overexpression deleteriously affects the growth of glioblastoma cells through miR-185-5p/Krüppel-like factor 16 axis.
    Zhang L; Cao Y; Wei M; Jiang X; Jia D
    J Cell Biochem; 2018 Nov; 119(11):9081-9089. PubMed ID: 29953649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ropivacaine represses the proliferation, invasion, and migration of glioblastoma via modulating the microRNA-21-5p/KAT8 regulatory NSL complex subunit 2 axis.
    Deng Z; Jian Y; Cai H
    Bioengineered; 2022 Mar; 13(3):5975-5986. PubMed ID: 35191804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma.
    Du W; Chen D; Wei K; Yu D; Gan Z; Xu G; Yao G
    Tohoku J Exp Med; 2023 Jul; 260(3):205-214. PubMed ID: 37019647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.